Glenmark Life Sciences IPO – Should you invest?
The rush to IPO continues. This time for a subsidiary of a Pharma major - Glenmark Pharma. The company had spun off its API business in 2019 & understandably ...
Like our content? Join Capitalmind Premium.
- Equity, fixed income, macro and personal finance research
- Model equity and fixed-income portfolios
- Exclusive apps, tutorials, and member community
Subscribe Now
Or start with a free-trial
Already a subscriber?
Login Now
Related Posts
Niva Bupa Health Insurance: Structural tailwinds in play
Niva Bupa Health Insurance is one of the largest and fastest growing standalone health insurer (SAHI) in India and is coming up with an IPO to raise 2,200 Cr. ...
Tata Technologies: Driving ER&D Innovation, Accelerating Tata Motors’ Debt Reduction
This post is unlocked with the 14-day free trail. Find the link below👇 to start your free trial. You remember Tata Technologies IPO? What's happening now? ...
RR Kabel IPO: Is It Worth the Buzz?
This post is unlocked for users taking up our 14-day free trail. Start your free trail now. Against the backdrop of markets hitting an all-time high, the ...